Bringing you extra in 2018

19 March 2018 0

The Cancer World team hopes that all our readers have had a good start to 2018. We look forward to bringing you critical, independent and rounded coverage of the big stories affecting quality cancer care [more]

The Cancer World team hopes that all our readers have had a good start to 2018. We look forward to bringing you critical, independent and rounded coverage of the big stories affecting quality cancer care that are set to develop... [ more ]

The toxic effects of hidden costs

A growing body of literature has described the so called “financial toxicity” of cancer, a common consequence of treatments, that sometimes leads patients to bankruptcy, and affects quality of life and clinical outcomes. “We don’t [more]

A growing body of literature has described the so called “financial toxicity” of cancer, a common consequence of treatments, that sometimes leads patients to bankruptcy, and affects quality of life and clinical outcomes.
... [ more ]

Math models for medical decision-making: a double-edged sword

In the golden age of computing, both the present and future of medical decision-making seem to depend on new mathematical models and systems built around artificial intelligence (AI). But how will doctors and patients feel [more]

In the golden age of computing, both the present and future of medical decision-making seem to depend on new mathematical models and systems built around artificial intelligence (AI). ... [ more ]

Navigating uncertainty in the era of MMM

3 March 2018 0

Some scholars recently coined the expression “Medical Misinformation Mess” to describe current clinical medicine as a realm in which it is very difficult to evaluate both reliability and practical meaning of research studies. A realm [more]

Some scholars recently coined the expression “Medical Misinformation Mess” to describe current clinical medicine as a realm in which it is very difficult to evaluate both reliability and practical meaning of research studies. A re... [ more ]

Precision medicine is making progress in NSCLC

Clinical oncologists face many challenges to identify the best use of the anti-EGFR drugs in patients with non-small-cell-lung cancer. Thanks to genetic analysis, they are now able to identify responders from non-responders and to counteract [more]

Clinical oncologists face many challenges to finding the right way to use the anti-EGFR drugs in patients with non-small-cell-lung cancer. Thanks to genetic analysis, they are now able to identify responders from non-responders an... [ more ]

The silent cancer refugees crisis

14 February 2018 1

Relief efforts aim at primary care, leaving refugees and displaced people with cancer without treatments or psychological support. In a worsening scenario, doctors are daily confronted with the hard choice between using the scarce resources [more]

Relief efforts aim at primary care, leaving refugees and displaced people with cancer without treatments or psychological support. In a worsening scenario, doctors are daily confronted with the hard choice between using the scarce... [ more ]